Login
← Go Back
Piramal Pharma
PPLPHARMA · Pharma > Pharmaceuticals & Drugs Listing date: Oct. 19, 2022
Stock Price vs Company Growth
1d
5.6%
1w
6.2%
1m
11.8%
3m
9.7%
6m
44.2%
1y
111.7%
all
13.0%
🤔 How to analyze this graph?
Use @ for users, # for companies and : for emojis
 
 
 
 
Last Traded Price
₹ 151 5.6%
114
154
Company Overview
Sales
7,782 Cr
Growth: 9.7%
Profit after Tax
-33.3 Cr
Growth: -75.1%
Mid Cap
19,990 Cr
P/S: 2.6x
Industry P/S: 2.6x
Fundamentals
Sales (Cr) ₹ 7,782
Growth 9.7%
EBITDA 13.1%
P/S 2.6x
Dividend 0.0%
P/E -521.0x
Book Value ₹ 51.5
PEG Ratio -53.6x
ROE -0.5%
P/B 2.9x
Shareholding Pattern
Institutions
Promoters
Others
Increase    Decrease    No change
Company Profile Detailed
The company offers a portfolio of differentiated products and services through end-to-end manufacturing capabilities across many global facilities and a global distribution network in hundreds of countries. It includes PPS, PCC and the India Consumer Healthcare business, selling over-the-counter products.
Belongs to (16 Indices) view more
Investors (4)
chethan3
an.sujay
ravi_kum...